Director of NGS & Transcriptomics within Translational Genomics at AstraZeneca’s R&D site in Gothenburg, Sweden. Graham has over 35 years experience across Pharma, Biotech and academia, applying Transcriptomics, Bioinformatics, orthogonal functional genetics and biotechnology to the discovery of new medicines.
In AstraZeneca Graham leads a research-orientated Nucleic Acids Omics laboratory that partners pre-clinical/clinical projects across the whole of AstraZeneca and with academic collaborators. The lab primarily focuses on NGS and associated technologies; generating transcriptomic, epigenetic and genetic smart data for both single and multi-omic projects. To this end they employ bulk, single cell, spatial, short and long read technologies together with automation, with the aim to stretch these technologies to increase the value they bring to drug discovery, and enhancing our understanding of disease and the fundamental processes of biology.